Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Adverse effects | |||||
Systematic review |
Women with primary dysmenorrhoea |
Adverse effects
with aspirin with placebo Absolute results not reported |
RR 1.3 95% CI 0.79 to 2.17 |
Not significant | |
Systematic review |
Women with primary dysmenorrhoea |
Nausea
with aspirin with placebo Absolute results not reported |
RR 1.66 95% CI 0.59 to 4.67 |
Not significant | |
Systematic review |
Women with primary dysmenorrhoea |
Dizziness
with aspirin with placebo Absolute results not reported |
RR 1.29 95% CI 0.28 to 5.89 |
Not significant | |
Systematic review |
Women with primary dysmenorrhoea |
Headache
with aspirin with placebo Absolute results not reported |
RR 0.60 95% CI 0.18 to 2.04 |
Not significant | |
Systematic review |
Women with primary dysmenorrhoea 2 RCTs in this analysis |
Gastrointestinal adverse effects
with aspirin with placebo Absolute results not reported |
OR 1.41 95% CI 0.55 to 3.60 P = 0.48 |
Not significant | |
Systematic review |
96 women Data from 1 RCT |
Neurological adverse effects
with aspirin with placebo Absolute results not reported |
OR 3.66 95% CI 0.75 to 17.78 P = 0.11 |
Not significant |